Significant proximal femoral bone deficiency in revision hip surgery poses a considerable challenge, especially as revision hip surgery is increasing in prevalence. Many femoral prosthetic devices, which compensate for this bone loss, are available to surgeons but ideally one wants to restore viable proximal bone stock. The Oxford Universal Hip (OUH) has been designed and modified with these challenges in mind. This is atrimodular, non-locking device that allows for some rotation and subsidence in the cement. Load transfer occurs at the proximal wedge, thus avoiding proximal stress shielding. The OUH has been used extensively in both primary and revision hip surgery and is particularly useful when used in conjunction with proximal impaction bone grafting. The main aim of this study was to determine the clinical outcome of the patients. The viability and survivorship of the impacted bone graft was assessed in order to give some indication of adequate perfusion of the incorporated bone grafting. Between 1999 and 2002 the OUH, in combination with proximal impaction bone grafting, was implanted in 72 hip revisions in 69 patients. All patients were clinically evaluated using the Oxford Hip score. Histological samples of impacted bone grafting were analysed by a pathologist 2 years after implantation to assess viability and perfusion of the impacted bone graft. The Oxford Hip Score improved from a pre-operative to a post-operative score of 45 (26–58) to 24.3 (12–43) respectively (p<
0.001). The mean follow up time was 32.7 months and in that time there were no re-revisions for aseptic loosening. Histology demonstrated viable bone stock in the proximal femur where bone grafting had been impacted 2 years previously. The OUH is a versatile hip prosthesis for use in revision hip arthroplasty and is especially well suited to proximal impaction bone grafting where it is possible to restore viable bone stock
Bone stock loss secondary to debris and mechanic alin-stability presents a challenge in revision hip arthroplasty. The aim of our study is to evaluate the clinical outcome of revision hip arthroplasty using the Oxford hip prosthesis combined with impaction allografting. Between 1999 and 2002, we revised 72 hips in 69 patients using this technique (mean age 65years). Indications were aseptic loosening (56), infection (8), peri-prosthetic fracture (7) and a broken stem (1). The mean time to revision was 8.5 years (1–21years). Patients were assessed clinically and with the Oxford Hip Score (OHS) pre- and post-operatively. Fifty-seven patients also had acetabular revision. Four patients required femoral osteotomy to remove the old prosthesis. We used a mean of 1.8 (1–4) femoral heads per operation. Patients were mobilised partially weight bearing (8weeks) followed by a gradual return to full loading. Complications included peri-operative femoral fracture (6), infection (6), dislocation (10), DVT (1)and PE (2). The average blood transfusion was 1.8 units (0–9). The OHS improved from 45 (26–58) pre-operatively to 24.3 post-operatively (12–43). No hip has been re-revised for aseptic loosening at a mean follow-up of 32.7months (16–51). The Oxford hip is a trimodular prosthesis with a polished tapered metaphyseal section that is free to slide and rotate on the stem. The stem is first inserted uncemented into the diaphysis. Bone graft is impacted proximally, with mesh if necessary, and then the proximal wedge is cemented in. The wedge allows for some subsidence in the cement and creates optimal radial force transmission, which is essential for bone-remodelling stimulation and preventing proximal stress shielding. Although this is a short-term experience, we believe that the use of the tri-modular Oxford stem combined with minimal proximal impaction allografting is a reliable method of dealing with difficult revision femoral surgery. The results were comparable with a primary arthroplasty in terms of pain relief and functional results.
The Charnley Elite femoral component was first introduced in 1992 as a new design variant of the original Charnley femoral component (De Puy, Leeds, UK) with modified neck and stem geometry. The original component had undergone few changes in nearly forty years and has excellent long-term results. Early migration of the new stem design was determined by Roentgen Stereophotogrammetric Analysis (RSA)1. Rapid early migration of a component relative to the bone, measured by RSA, is predictive of subsequent aseptic loosening for a number of femoral stems. As there was rapid early migration and rotation of the Charnley Elite stem, we predicted that the long-term results would be poor. An outcome assessment is indicated as stems of this type are still being implanted. One hundred Charnley Elite stems, implanted in our centre between 1994 and 1997 were included in a prospective, cross-sectional follow-up study. Outcome measures include validated clinical scores (Charnley hip score, Harris hip score and Oxford hip score) and radiological scores (Gruen classification) as well as revision rates over the past 10 years. The clinical follow-up supports the RSA predictions of early failure of the Charnley Elite femoral stem.
Early migration of the new stem design was determined by Roentgen Stereophotogrammetric Analysis (RSA). Rapid early migration of a component relative to the bone, measured by RSA, is predictive of subsequent aseptic loosening for a number of femoral stems. As there was rapid early migration and rotation of the Charnley Elite stem, we predicted that the long-term results would be poor. An outcome assessment is required as stems of this type are still being implanted.
Preliminary clinical scores in the patients who had not undergone any subsequent surgery were adequate (Oxford Hip Score mean average of 23.9). Thirteen percent of radiographs analysed had evidence of loosening, giving an overall loosening rate of 14% at 8 years.
Between 1999 and 2002, we revised 72 hips in 69 patients using this technique (mean age 65years, 28 to 88). Fifty-six cases had aseptic loosening, 8 had infection (2 stages), 7 had peri-prosthetic fractures and 1 had a broken stem. The mean time to revision was 8.5years (1 to 21). Patients were assessed clinically and with the Oxford Hip Score (OHS) pre- and post-operatively. Fifty-seven patients also had acetabular revision. Four patients required femoral osteotomy to remove the old prosthesis. We used a mean of 1.8 (1 to 4) femoral heads per operation. Complications included 6 peri-operative femoral fractures diagnosed at operation and fixed successfully, 6 infections, 10 dislocations (2 were recurrent), one deep vein thrombosis, 2 pulmonary embolism and one gastrointestinal haemorrhage. The average blood transfusion was 1.8 units (0 to 9). The OHS improved from 45 (26 to 58) pre-operatively to 24.3 post-operatively (12 to 43). No hip has been re-revised for aseptic loosening at a mean follow-up of 32.7 months (16 to 51).
